We are live on
!
Find out more
AIIC
AJU IB Investment Company Portfolio holdings
AUM
$30.5M
1-Year Est. Return
128.96%
This Fund
S&P 500
This Quarter
Est. Return
+50.75%
1 Year Est. Return
+128.96%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$264M
AUM Growth
–
Cap. Flow
+$226M
Cap. Flow
% of AUM
85.57%
Top 10 Holdings %
Top 10 Hldgs %
99.97%
Holding
11
New
11
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seer Inc
SEER
|
+$67.8M |
| 2 |
Atea Pharmaceuticals
AVIR
|
+$66.1M |
| 3 |
APLS
Apellis Pharmaceuticals
APLS
|
+$47.2M |
| 4 |
Kymera Therapeutics
KYMR
|
+$34.3M |
| 5 |
RAPT
RAPT Therapeutics
RAPT
|
+$2.95M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
LGM
OGC
AC
PL
WVP
VL
CPM
SP
AJU IB Investment Company's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for AJU IB Investment Company, which disclosed 11 positions worth $264M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Seer Inc: 1,066,375 shares worth $59.9M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- AJU IB Investment Company's largest Q4 2020 buy was Seer Inc: 1,066,375 shares worth $59.9M.
- AJU IB Investment Company's ten largest holdings make up 100% of its $264M portfolio in Q4 2020.
- AJU IB Investment Company disclosed 11 positions in Q4 2020, its first 13F filing on record.
Based on AJU IB Investment Company's 13F filing for Q4 2020, filed 12 May 2021.